1. Home
  2. Labeler Index
  3. Nucare Pharmaceuticals,inc.
  4. NDC Product Code: 70859-035 Nudroxipak E-400

NDC 70859-035 Nudroxipak E-400

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 70859-035?
  5. Nudroxipak E-400 Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
70859-035
Proprietary Name:
Nudroxipak E-400
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Nucare Pharmaceuticals,inc.
Labeler Code:
70859
Product Label ID:
678f5379-b080-392c-e053-2991aa0a0abf
Start Marketing Date: [9]
03-16-2018
Listing Expiration Date: [11]
12-31-2022
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
OVAL (C48345)
Size(s):
19 MM
Imprint(s):
APO;041;400
Score:
1

Product Packages

NDC Code 70859-035-01

Package Description: 1 KIT in 1 CARTON * 1 CONTAINER in 1 CARTON (70859-028-03) / 90 mL in 1 CONTAINER * 100 TABLET, FILM COATED in 1 BOTTLE (60505-0041-1)

Product Details

What is NDC 70859-035?

The NDC code 70859-035 is assigned by the FDA to the product Nudroxipak E-400 which is product labeled by Nucare Pharmaceuticals,inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 70859-035-01 1 kit in 1 carton * 1 container in 1 carton (70859-028-03) / 90 ml in 1 container * 100 tablet, film coated in 1 bottle (60505-0041-1). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Nudroxipak E-400?

Carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Etodolac tablets, USP are indicated:For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For the management of acute pain

Which are Nudroxipak E-400 UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Nudroxipak E-400 Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Nudroxipak E-400?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 197686 - etodolac 400 MG Oral Tablet
  • RxCUI: 1989491 - capsaicin 0.025 % / menthol 6 % / methyl salicylate 25 % Topical Solution
  • RxCUI: 1989491 - capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".